SINEMET CR 521
Generic Name: carbidopa/levodopa
Pill imprint SINEMET CR 521 has been identified as Sinemet CR 50 mg / 200 mg.
Sinemet CR is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Sinemet CR 50 mg / 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Sinemet CR Images
- Generic Name:
- carbidopa/levodopa
- Imprint:
-
SINEMET CR
521 - Strength:
- 50 mg / 200 mg
- Color:
- Peach
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- hydroxypropyl cellulose
magnesium stearate
ferric oxide red
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00056-0521
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-1882 | Physicians Total Care Inc (repackager) |
| 67544-0241 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Sinemet CR resources
- Sinemet CR Sustained-Release Tablets (Wolters Kluwer)
- Sinemet CR (Cerner Multum)
- Sinemet CR (FDA)
Search Again
